BACKGROUND: Since the serotonin (5-HT) is associated with circadian rhythm and breathing regulation, the serotonin transporter (5-HTT), which plays an important role in serotoninergic transmission, might be a strong candidate gene in the pathogenesis of obstructive sleep apnea syndrome (OSAS). OBJECTIVE: To investigate the association of 5-HTT gene polymorphisms with OSAS and clinical characteristics. METHODS: We genotyped the 5-HTT gene linked polymorphic region (5-HTTLPR) and a variable number of tandem repeats at intron 2 (STin2.VNTR) in 254 OSAS patients and 338 healthy controls in Chinese Han population. RESULTS: In total sample, the 10-repeat allele of STin2.VNTR was significantly associated with OSAS (P = 0.007, OR = 1.72, 95% CI = 1.15-2.58), but no association was found in 5-HTTLPR. In male subjects, both polymorphisms showed significant association with OSAS (Allele L: P = 0.005, OR = 1.44, 95% CI = 1.11 to 1.87; Allele 10: P = 0.002, OR= 1.94, 95% CI = 1.26 to 3.00). Two haplotypes, S-12 and L-10, constructed by the above polymorphisms also revealed significant associations with OSAS (global P-values were 0.020 for total sample and 0.0006 for male subjects, respectively). Male patients carrying the haplotype S-12 showed a significantly lower apnea / hypopnea index (AHI), depressive factor, plasma 5-HT level and 5-hydroxyindolacetic acid (5-HIAA) levels, but higher episodic memory, when compared with non-S-12 carriers (P < 0.05). However, no significant differences were found in excessive daytime sleepiness or other psychological function across haplotype carriers (P > 0.05). CONCLUSIONS: These findings support that 5-HTT gene may be involved in susceptibility to OSAS, especially with sex-dependent effect.
BACKGROUND: Since the serotonin (5-HT) is associated with circadian rhythm and breathing regulation, the serotonin transporter (5-HTT), which plays an important role in serotoninergic transmission, might be a strong candidate gene in the pathogenesis of obstructive sleep apnea syndrome (OSAS). OBJECTIVE: To investigate the association of 5-HTT gene polymorphisms with OSAS and clinical characteristics. METHODS: We genotyped the 5-HTT gene linked polymorphic region (5-HTTLPR) and a variable number of tandem repeats at intron 2 (STin2.VNTR) in 254 OSAS patients and 338 healthy controls in Chinese Han population. RESULTS: In total sample, the 10-repeat allele of STin2.VNTR was significantly associated with OSAS (P = 0.007, OR = 1.72, 95% CI = 1.15-2.58), but no association was found in 5-HTTLPR. In male subjects, both polymorphisms showed significant association with OSAS (Allele L: P = 0.005, OR = 1.44, 95% CI = 1.11 to 1.87; Allele 10: P = 0.002, OR= 1.94, 95% CI = 1.26 to 3.00). Two haplotypes, S-12 and L-10, constructed by the above polymorphisms also revealed significant associations with OSAS (global P-values were 0.020 for total sample and 0.0006 for male subjects, respectively). Male patients carrying the haplotype S-12 showed a significantly lower apnea / hypopnea index (AHI), depressive factor, plasma 5-HT level and 5-hydroxyindolacetic acid (5-HIAA) levels, but higher episodic memory, when compared with non-S-12 carriers (P < 0.05). However, no significant differences were found in excessive daytime sleepiness or other psychological function across haplotype carriers (P > 0.05). CONCLUSIONS: These findings support that 5-HTT gene may be involved in susceptibility to OSAS, especially with sex-dependent effect.
Authors: K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy Journal: Science Date: 1996-11-29 Impact factor: 47.728
Authors: S Battersby; A D Ogilvie; C A Smith; D H Blackwood; W J Muir; J P Quinn; G Fink; G M Goodwin; A J Harmar Journal: Psychiatr Genet Date: 1996 Impact factor: 2.458
Authors: Eszter Dömötör; Andrea Sárosi; Gabriella Balogh; Anna Székely; Krisztina Héjjas; Mária Sasvári-Székely; Gábor Faludi Journal: Neuropsychopharmacol Hung Date: 2007-06
Authors: S Redline; P V Tishler; T D Tosteson; J Williamson; K Kump; I Browner; V Ferrette; P Krejci Journal: Am J Respir Crit Care Med Date: 1995-03 Impact factor: 21.405
Authors: Michael Deuschle; Michael Schredl; Claudia Schilling; Stefan Wüst; Josef Frank; Stephanie H Witt; Marcella Rietschel; Magdalena Buckert; Andreas Meyer-Lindenberg; Thomas G Schulze Journal: Sleep Date: 2010-03 Impact factor: 5.849
Authors: Laila Simpson; David R Hillman; Matthew N Cooper; Kim L Ward; Michael Hunter; Stewart Cullen; Alan James; Lyle J Palmer; Sutapa Mukherjee; Peter Eastwood Journal: Sleep Breath Date: 2012-11-16 Impact factor: 2.816
Authors: Gérard Hilaire; Nicolas Voituron; Clément Menuet; Ronaldo M Ichiyama; Hari H Subramanian; Mathias Dutschmann Journal: Respir Physiol Neurobiol Date: 2010-08-27 Impact factor: 1.931
Authors: Han Chen; Brian E Cade; Kevin J Gleason; Andrew C Bjonnes; Adrienne M Stilp; Tamar Sofer; Matthew P Conomos; Sonia Ancoli-Israel; Raanan Arens; Ali Azarbarzin; Graeme I Bell; Jennifer E Below; Sung Chun; Daniel S Evans; Ralf Ewert; Alexis C Frazier-Wood; Sina A Gharib; José Haba-Rubio; Erika W Hagen; Raphael Heinzer; David R Hillman; W Craig Johnson; Zoltan Kutalik; Jacqueline M Lane; Emma K Larkin; Seung Ku Lee; Jingjing Liang; Jose S Loredo; Sutapa Mukherjee; Lyle J Palmer; George J Papanicolaou; Thomas Penzel; Paul E Peppard; Wendy S Post; Alberto R Ramos; Ken Rice; Jerome I Rotter; Scott A Sands; Neomi A Shah; Chol Shin; Katie L Stone; Beate Stubbe; Jae Hoon Sul; Mehdi Tafti; Kent D Taylor; Alexander Teumer; Timothy A Thornton; Gregory J Tranah; Chaolong Wang; Heming Wang; Simon C Warby; D Andrew Wellman; Phyllis C Zee; Craig L Hanis; Cathy C Laurie; Daniel J Gottlieb; Sanjay R Patel; Xiaofeng Zhu; Shamil R Sunyaev; Richa Saxena; Xihong Lin; Susan Redline Journal: Am J Respir Cell Mol Biol Date: 2018-03 Impact factor: 6.914
Authors: Carmen M Schröder; Michelle M Primeau; Joachim F Hallmayer; Laura C Lazzeroni; Jeffrey T Hubbard; Ruth O'Hara Journal: Int J Geriatr Psychiatry Date: 2013-06-11 Impact factor: 3.485